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in and on our bodies form a functional organ 
that is fundamental to our health and physi-
ology (Fig.  1). Together with our symbiotic 
microbial residents, we form a ‘superorgan-
ism’, or holobiont. The microbial component 
of the human holobiont is substantial, and at 
least equals the number of our own cells.2 The 
Introduction
Humans, like all complex multicellular eukary-
otes, are not autonomous organisms, but bio-
logical units that include numerous microbial 
symbionts and their genomes.1 The microbes 
For millions of years, our resident microbes have coevolved and coexisted with us in a mostly harmonious symbiotic 
relationship. We are not distinct entities from our microbiome, but together we form a ‘superorganism’ or holobiont, 
with the microbiome playing a significant role in our physiology and health. The mouth houses the second most diverse 
microbial community in the body, harbouring over 700 species of bacteria that colonise the hard surfaces of teeth and 
the soft tissues of the oral mucosa. Through recent advances in technology, we have started to unravel the complexities 
of the oral microbiome and gained new insights into its role during both health and disease. Perturbations of the oral 
microbiome through modern-day lifestyles can have detrimental consequences for our general and oral health. In dysbiosis, 
the finely-tuned equilibrium of the oral ecosystem is disrupted, allowing disease-promoting bacteria to manifest and cause 
conditions such as caries, gingivitis and periodontitis. For practitioners and patients alike, promoting a balanced microbiome 
is therefore important to effectively maintain or restore oral health. This article aims to give an update on our current 
knowledge of the oral microbiome in health and disease and to discuss implications for modern-day oral healthcare.
community of our microbial residents is referred 
to as our microbiome, a term that was coined 
by the Nobel prize laureate Joshua Lederberg ‘to 
signify the ecological community of commensal, 
symbiotic, and pathogenic microorganisms 
that literally share our body space and have 
been all but ignored as determinants of health 
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Fig. 1  Positive effects of host-microbiome symbiosis
In brief
Summarises the benefits of a health-
promoting oral microbiome for oral and 
general health.
Provides an overview of coevolution 
between humans and oral microbes.
Reviews factors associated with 
dysbiosis and implications for caries and 
periodontal disease.
Highlights existing strategies to 
preserve a balanced oral microbiome 
for practitioners and patients to follow.
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and disease’.3 The emergence of new genomic 
technologies, including next-generation 
sequencing (NGS) and bioinformatic tools, 
has provided a powerful means of understand-
ing the contribution of the human microbiome 
to health. Ventures started in the last decade, 
such as the Human Microbiome Project4 and 
Metagenomics of the Human Intestinal Tract 
(MetaHIT),5 have generated the resources and 
expertise needed to characterise and understand 
the human microbiome. Our knowledge is set 
to grow further with future undertakings such 
as the recently announced National Microbiome 
Initiative, a partnership between federal US 
agencies, academia, charitable organisations and 
the private sector, who collectively have pledged 
over US$ 500 million in research funding.6 We 
have learned that we are not colonised at random, 
but that our microbial residents have coevolved 
with us over millions of years. The relationship 
between microbiome and host is dynamic, and 
influenced by many aspects of modern lifestyle, 
such as diet, tobacco consumption and stress, 
which can alter our microbiome and its proper-
ties, and induce a state in which this finely tuned 
ecosystem is no longer in balance. To address this 
divergence and maintain a harmonious state to 
protect health and prevent disease, we must not 
focus on the host and its residents as separate 
units, but instead consider the holobiont as one.
The mouth is one of the most heavily 
colonised parts of our bodies. Several distinct 
habitats within the oral cavity support hetero-
geneous microbial communities that constitute 
an important link between oral and general 
health. The purpose of this article is to update 
oral healthcare practitioners on our current 
knowledge of the oral microbiome in health 
and disease, to review how molecular methods 
of microbial characterisation have advanced our 
understanding, and to discuss potential implica-
tions for clinical practice. For an introduction to 
key terms used throughout the text (highlighted 
in bold), please see the glossary in Table 1.
The oral microbiome: discussion
Our current understanding of 
the biological evolution of the 
microbiome
There is evidence that resident microbes 
have been performing metabolic functions 
in animals for at least 500 million years.7 
Coevolution is documented by the many 
similarities in the composition and organisa-
tion of the human microbiome to that of other 
mammals.8 The history of the relationship 
Table 1  Definitions of key terms
Term Definition
16S ribosomal RNA (16S rRNA) An RNA molecule (approximately 1500 nucleotides long) that is part of the small subunit of the ribosome in prokaryotes. 16S rRNA has both highly conserved regions, common to all prokaryotes, and hypervariable regions that are unique to particular species
Biofilm A sessile community of microbes characterized by cells that are attached to a surface or to each other and embedded in a matrix of extracellular polymeric substances20
Bioinformatics The application of computational techniques to analyse complex biological data such as genetic codes
Coevolution The parallel evolution of interacting species
Community profiling Characterisation of complex microbial communities by their 16S rRNA gene sequences
Dysbiosis A condition in which the normal microbiome population structure is disturbed, often through external burdens such as disease states or medications7
Epigenetics The study of heritable changes in gene expression that are not caused by changes in DNA sequence95
Gene amplification An increase of gene copies by laboratory methods for research purposes.* Amplification of a gene produces enough copies of a gene to allow for gene sequencing
Gene sequencing A laboratory method to determine the precise order of nucleotides within a DNA molecule, enabling scientists to decipher genetic information that is carried in a particular DNA segment (for example, the 16S rRNA gene)
Holobiont The host organism and all its symbiotic microbial residents1
Metagenomics Analysis of the genetic information of a complex population, typically from microbes in an environmental or host sample. The metagenome consists of the genomes of many individual microbes7
Metatranscriptomics Analysis of the active genes and species of the microbiome96
Microbiome The sum of microbes, their genetic information, and the environment in which they interact7
Microbiota All living microbial organisms constituting the microbiome7
Next-generation sequencing (NGS) An umbrella term to describe a number of different modern high throughput sequencing technologies
Operational taxonomic unit (OTU) The grouping of bacterial 16S rRNA gene sequences by their similarity.
7 Sequences are typically grouped at a value between 97% 
and 99%
Phenotype The observable physical characteristics of an organism, for example, appearance, behaviour or clinical presentation
Phylogenetics The study of the evolutionary relationships among groups of organisms
Phylotype A type of bacterium defined by its placement in a phylogenetic tree on the basis of its16S rRNA gene sequence
Species Coherent and distinct groups of bacteria that have been isolated, cultured and named*
Symbiosis Two or more species living closely together in a long-term relationship1
*For the purpose of this manuscript.
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between microorganisms and humans is 
outlined in Figure 2. In humans, coevolution 
has also resulted in minor, but important, dif-
ferences between ethnic groups.9–12 The genetic 
material of microbes has followed us on our 
exodus from the birthplace of the human race 
in Africa and has been used alongside human 
markers to trace migration routes across the 
planet.11 In fact, detailed examination of strains 
of Helicobacter pylori may allow us to distinguish 
more accurately between human populations 
than a comparison of human genetic markers.11
Throughout human evolution, our environ-
ment has continuously shaped the composition 
of our microbiome, increasingly so during 
Neolithic, industrial revolution and modern 
eras.13 The use of fire, invention of agriculture, 
increased access to processed foods, including 
refined sugar after the industrial revolution, 
and the advent of antimicrobial therapy, are 
all likely to have influenced the composition 
of the human microbiome.13
Temporal changes in the oral microbiome
A study of calcified dental plaque samples 
from the time of transition from hunter-gather 
to Neolithic societies, and from the industrial 
revolution has proposed a compositional 
shift and declining microbial diversity around 
each of these evolutionary milestones.14 It is, 
however, reasonable to point out that there 
are limitations of microbiome determinations 
from ancient preserved samples compared with 
viable microbes sampled in modern day,15 and 
these findings need to be interpreted with care. 
Introduction of refined sugar to our diet in the 
early times of agriculture caused certain oral 
bacteria to genetically evolve their metabolism 
to adapt to ‘post-agricultural’ changes in our 
diet. For example, Streptococcus mutans was 
able to successfully compete against other oral 
bacterial species by developing defences against 
increased oxidative stress and resistance against 
the acidic by-products of its own new efficient 
carbohydrate metabolism.16 This adaptation led 
to its increased prevalence in the oral cavity, along 
with other acid-tolerant species. In addition, 
since the industrial revolution, humans have 
been more frequently exposed to agents such 
as heavy metals, disinfectants, biocides and 
antibiotics that have the potential to eradicate or 
debilitate many microorganisms, while positively 
selecting for those microbes that carry resistance 
determinants.13 Oral hygiene practice changed 
towards the end of the nineteenth century in 
the developed world, mainly prompted by the 
publication of Willoughby Miller’s book ‘Micro-
organisms of the human mouth’ in 1890, which 
generated a worldwide promotion of tooth 
brushing and flossing.17 This, too, is likely to have 
been a major factor in changes in the composi-
tion of the oral microbiome.18 The modern-day 
excessive consumption of acidic drinks and 
refined sugar or cigarette smoking has further 
impacted on the oral ecosystem,14 leading to 
diseases such as caries and periodontal disease.
The human microbiome is a complex 
ecological community
We know now that the microorganisms (the 
microbiota) that make up the human micro-
biome are not just unicellular organisms living 
alongside each other, but instead form highly 
regulated, structurally and functionally organised 
communities attached to surfaces as biofilms,19 
with interspecies collaborations as well as 
antagonisms that contribute to ecologic stability. 
Bacteria within a biofilm can communicate 
with each other by producing, detecting and 
responding to small diffusible signal molecules in 
a process called quorum sensing, which confers 
benefit for host colonisation, biofilm formation, 
defence against competitors and adaptation to 
changes in the environment.19 Quorum-sensing 
activities in biofilms are also involved in the 
virulence and pathogenic potential of bacteria 
and are therefore an important factor in under-
standing and controlling bacterial infections,19 
as they enable microorganisms in biofilms to 
become more tolerant of host defences and anti-
microbial agents.20
The endogenous human microbial com-
munities contribute to critical metabolic, 
physiological and immunological functions, 
including:21–24
• Differentiation and maturation of the host 
mucosa and its immune system
• Food digestion and nutrition
• Energy generation
• Metabolic regulation and control of fat 
storage
• Processing and detoxification of environ-
mental chemicals
• Maintenance of skin and mucosa barrier 
function
• Development and regulation of the immune 
system and fine-tuning of its reaction 
pattern, that is, the balance between pro-
inflammatory and anti-inflammatory 
processes
• Prevention of invasion and growth of 
disease-promoting microorganisms (colo-
nisation resistance). 
Perturbations to the function and composi-
tion of the microbiome can have significant 
consequences for human health.7 
The composition of our microbiome shows 
great diversity between compartments in the 
body, and is highly variable within and between 
people.25 It has been suggested that a person’s gut 
bacteria and the community of microbes that 
live in the body and on the skin are distinct 
enough from the rest of the population to 
be used as a unique microbial ‘fingerprint’.26 
Nonetheless, genetic variation in the human 
host is a dominant source of variation in com-
position of the microbiome, and twins share 
more similarities between their gut microbi-
omes than a twin and a parent or a non-twin 
sibling.27 Despite variations in the composition 
Fig. 2  History of the relationship between microorganisms and humans: The coevolution 
between microorganisms (blue lines) and their respective hosts (green lines) over a period of 
1.5 billion years has resulted in mutual adaptation and functional integration as reflected in 
our own relationship to most of the microorganisms that colonise our body surfaces (Homo 
sapiens, red line)
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of the microbiomes between individuals, it is 
important to note that the overall functions of 
their microbiota are relatively consistent.13
Different body sites support entirely distinct 
microbial communities due to differences in 
prevailing biological and physical properties 
of each location/habitat.25 High specificity per 
body site was demonstrated by Kuczynski et al.: 
by using only ten randomly selected sequences 
from microbiome datasets, they could dis-
criminate among the different body sites from 
which the samples were taken.28 The most 
diverse bacterial populations are found in the 
gastrointestinal tract and the mouth.29
Special considerations for the oral 
microbiome
The mouth is not a homogeneous environment 
for the resident microbiota, but offers several 
distinct habitats for microbial colonisation,30 such 
as teeth, gingival sulcus, attached gingiva, tongue, 
cheek, lip, and hard and soft palate. These oral 
habitats form a highly heterogeneous ecological 
system and support the growth of significantly 
different microbial communities.31 The warm and 
moist environment in the mouth suits the growth 
of many microorganisms and offers host-derived 
nutrients, such as saliva proteins, glycoproteins 
and gingival crevicular fluid (GCF).32 The teeth 
are the only natural non-shedding surfaces in 
the human body and provide unique oppor-
tunities for extensive biofilm formation, and a 
secure haven for microbial persistence.33 Dental 
restorations, crown and bridgework, removable 
prostheses and implants constitute additional 
non-shedding surfaces in the mouth that can 
influence biofilm formation and composition.34–36
To date, more than 700 prokaryotic taxa have 
been detected in the oral cavity, many of which 
cannot be isolated by common culture methods.37 
Approximately 54% are validly named species, 
14% are unnamed (but cultivated) and 32% 
are known only as uncultivated phylotypes.37 
However, in any one individual, the number 
of resident species is estimated to be fewer. A 
detailed study of 9 oral sites in 26 subjects using 
DNA sequencing revealed a mean of 296 species-
level taxa in each individual, while 557 taxa were 
found among the 26 subjects (unpublished data; 
Dr Floyd Dewhirst, personal communication).
Acquisition of a normal oral 
microbiome
During birth, the mother transmits microbes 
to the child, and delivery mode (vaginal versus 
caesarean) is therefore a determinant for the type 
of microorganisms that a child is initially exposed 
to.38 Delivery mode also influences the diversity 
of the oral microbiome later on in an infant’s life, 
with vaginally-born children showing a higher 
number of taxa 3 months after birth compared 
with children born by caesarean section.39 
The method of feeding also has an effect, with 
3-month-old breast-fed infants showing a higher 
colonisation with oral lactobacilli than formula-
fed infants.40 The eruption of teeth provides new 
surfaces for microbial colonisation and consti-
tutes a major ecological event in the mouth of a 
child.41 By the age of three, the oral microbiome 
of children is already complex, and becomes 
increasingly so with age.42 Replacement of the 
primary teeth with an adult dentition again sig-
nificantly alters the oral microbial habitat.31
Maintaining a healthy oral 
microbiome
Once established, the oral microbiome is 
maintained by host- and microbe-derived 
factors, involving processes that are still not 
fully understood. Resident bacteria have both 
pro- and anti-inflammatory activities that are 
crucial for maintaining homeostasis at heavily 
colonised sites such as the oral cavity.43 Due to 
the interplay of the host’s immune system with 
its microbial symbionts, acute infections of 
the oral mucosa are rather rare, despite dense 
microbial colonisation.44 The importance of 
these host-microbe interactions is highlighted 
by observations in immunosuppressed patients, 
who can experience life-threatening viral and 
fungal infections of the mucous membranes and 
oral infections by non-oral species.45–47
Both saliva and GCF provide nutrients for 
microbial growth and contain components 
with antimicrobial activities.32,48,49 The role of 
saliva in promoting oral health is well estab-
lished.32 In addition to facilitating mastication, 
swallowing and speech, and aiding digestion, 
saliva contains vital enzymes and proteins 
that help maintain a balanced microbiota. Up 
to 108 microorganisms have been detected 
per millilitre of saliva, mostly derived from 
oral mucosal surfaces such as the tongue.50 
Salivary components are the primary nutri-
tional source for microorganisms, and are 
required for the development of a balanced 
microbiome. A large number of salivary 
components, including secretory immu-
noglobulin A, lactoferrin, lactoperoxidase, 
lysozyme, statherin and histatins, directly and 
indirectly regulate the microbiome, keeping 
it in balance.32 For example, lactoperoxidase 
catalyses the production of hypothiocyanite 
from hydrogen peroxide  –  a product of 
bacterial metabolism  –  and saliva-secreted 
thiocyanate. Hypothiocyanite exerts direct 
antimicrobial effects by inhibiting bacterial 
glycolysis.51 Another salivary component with 
antimicrobial potential is nitrite, converted 
from dietary nitrates by oral bacteria. Nitrite is 
further reduced to nitric oxide that can inhibit 
growth of cariogenic bacteria and thus may 
help to protect against caries.52
Fig. 3  Evolution of microbiological methods over time
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Proteins, including enzymes, lipids and other 
components (carbohydrates, nucleic acids), 
mainly from saliva, but also derived from GCF, 
the oral mucosa and bacteria, form the acquired 
pellicle, which modulates attachment of bacteria 
to dental and epithelial surfaces and protects the 
tooth surfaces against acid attacks.53 Enzymes 
that help to regulate the balance of the micro-
biome are immobilised in the acquired pellicle 
in an active conformation.54 The individually 
composed acquired pellicle triggers and mediates 
bacterial adherence to the non-shedding tooth 
surfaces via various interactions.
Saliva not only helps to maintain an environ-
ment that allows biofilms to flourish, but also 
modulates the layers of plaque with the help of 
numerous proteins, including enzymes and gly-
coproteins, and minerals, which control biofilm 
build-up and activity.32,55 Plaque biofilm is also 
dislodged by movement of the oral muscles of 
the cheeks and tongue during speech and mas-
tication and by the flow of saliva.
Characterisation of the oral 
microbiome
A variety of conventional methods have been 
used to analyse the composition of the oral 
microbiome, including microscopy, cultural 
analysis, enzymatic assays and immunoas-
says.56–58 Figure  3 provides an overview of 
how microbiological methods have evolved 
over the years. However, many oral bacteria 
are fastidious and slow-growing, and require 
complex growth media, specific atmospheric 
requirements and long incubation times. 
Many oral bacteria are strict anaerobes, and 
expert care must be taken in sample collection, 
transport and incubation to prevent exposure 
to oxygen. Comprehensive cultural analysis 
of samples is difficult and only allows for the 
processing of small sample numbers. Selective 
bacteriological media have proven useful for 
studying particular species of interest, but may 
have biased our understanding of microbial 
aetiology of oral disease, attributing disease 
characteristics to species that happen to thrive 
under such culture conditions, while others 
remain undetected.
The advent of culture-independent 
methods has greatly improved the detection 
of microorganisms, many of which cannot 
yet be grown in culture.57 The most common 
culture-independent technique to analyse the 
microbiome is based on 16S ribosomal RNA 
(16S rRNA) gene community profiling.57 The 
16S rRNA gene is present in all prokaryotes 
and contains variable regions that are unique 
between microorganisms and that can be used 
as a means of identification. 16S rRNA genes 
can be extracted from heterogeneous samples, 
amplified and sequenced, and then compared 
with databases such as the Human Oral 
Microbiome Database,37 a publically available 
online resource that links sequence data with 
phenotypic, phylogenetic, clinical and biblio-
graphic information of microorganisms found 
in the oral cavity. If a match for the sequence 
is found on the database, the microorganism 
can be identified; if there is no matching entry 
on the database, the sequence can be added as 
a record for a previously unknown phylotype.
The traditional method of 16S rRNA gene 
sequencing was costly, laborious and time-con-
suming. The advent of NGS methods such as 
454 pyrosequencing (which is currently being 
phased out) and Illumina MiSeq have enabled 
a massively increased sample throughput, with 
up to 27 million sequences being generated in 
a single run (compared with a few hundred 
with the traditional method). A more detailed 
description of NGS is shown in Figure 4. The 
simplicity and relative affordability of NGS 
has led to enormous data generation and an 
explosion in publications, with accompanying 
challenges for data analysis and interpreta-
tion. Great care has to be taken in the conduct 
of NGS studies to avoid contamination of 
clinical samples with bacterial DNA present 
in some extraction kits, laboratory reagents 
and sample collection tools, which can sig-
nificantly influence the outcome of studies.59,60 
Despite these caveats, NGS is a useful tool that 
allows for high-volume studies of the genetic 
material in samples and has greatly increased 
our knowledge and understanding of the oral 
microbiome.
Fig. 4  Overview of the next-generation sequencing pipeline
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Other modern approaches include 
metagenomics and metatranscriptomics. 
While metagenomics provides insights into 
the genetic composition of the microbial 
community in a sample, metatranscriptomics 
allows researchers to study the actively tran-
scribed genes.61 Both methods are, to date, still 
hampered by technical challenges, but provide 
great opportunities to further our knowledge 
of the collective genome of the oral microbi-
ome and its metabolic actions in the future.
Culture-independent methods have 
provided great insight into the diversity of the 
microbiome, but to investigate the properties 
and potential of an organism, it needs to be 
grown in culture. Currently, up to a third of the 
species in the oral microbiome are only known 
by their 16S rRNA gene sequence,62 and there is 
an ongoing quest to develop new methods for 
growing currently ‘uncultivatable’ microorgan-
isms.62 Progress in this area has been made, and 
a new method using siderophores (small, high-
affinity iron-chelating compounds secreted by 
microorganisms such as bacteria, fungi and 
grasses) has been developed to isolate and 
grow novel strains.62 Some isolates depend on 
‘helper strains’ for successful culture, implying 
their dependency on quorum-sensing and 
nutritional and/or signalling interactions with 
other bacteria within the biofilm community 
that they naturally inhabit.62
The application of such novel culturing 
methods, along with emerging molecular 
biological and bioinformatics approaches and 
increased computational power, will not only 
grow our understanding of the oral microbiome, 
but also help us devise interventional strategies 
to maintain health and target disease in future.
An unbalanced oral microbiome may 
be detrimental to general health
The oral microbiota contributes to oral and 
general well-being (Fig. 1), and its loss can be 
detrimental to the health of the individual. An 
example of this is the effect of nitrate-reduc-
tase-expressing oral bacteria, which have been 
shown to catalyse the conversion of dietary 
nitrates to nitrite. After being swallowed, 
salivary nitrite is further converted to nitric 
oxide, a potent vasodilator with antimicrobial 
activity which plays a critical role in sustaining 
cardiovascular health.63 Nitrite also stimulates 
gastric mucus production.64 A modest con-
sumption of nitrate has been found to lead 
to a reduction of blood pressure, inhibition 
of platelet function and reduced endothelial 
dysfunction.65 A recent study has found that 
sustained ingestion of dietary nitrates improves 
vascular function in patients with hypercholes-
terolaemia.66 These improvements were associ-
ated with changes in the oral microbiome in 
favour of organisms that are capable of nitrite 
reduction.66 However, while dietary nitrates 
are able to boost nitrite formation, it is also 
the case that nitric oxide in tissues can interact 
with superoxide radicals released by immune 
cells to form peroxynitrite anions, which have 
been suggested to have detrimental actions 
on cells, such as DNA damage.67 The subject 
of the effects of nitrate/nitrite/nitric oxide on 
health still evokes some controversy; however, 
several small-scale studies have shown that the 
use of chlorhexidine-containing mouthwashes 
can reduce the concentration of nitrites in both 
saliva and plasma and lead to a small rise in 
blood pressure.68–70 While these findings are 
interesting, it is important to note that confir-
mation from larger-scale studies is necessary 
before any firm conclusions can be drawn.
Dysbiosis: the oral microbiome in 
disease
The complex equilibrium between resident 
species in the oral cavity is responsible 
for the maintenance of a healthy state (in 
symbiosis) or a state associated with disease 
(in dysbiosis). A dysbiotic microbiome is one 
in which the diversity and relative propor-
tions of species or taxa within the microbiota 
is disturbed.7 The relationship between the 
oral microbiome and its host is dynamic and, 
while in the healthy mouth the composition 
of microbial communities is remarkably 
stable (after the microbiome has matured in 
childhood), biological changes in a person’s 
life can affect the balance of the species within 
these communities.71 These include physiologi-
cal changes, for example, age, or hormonal 
changes in puberty and pregnancy, to which 
healthy individuals can often adapt without 
detriment to their oral health.72 At other times, 
the finely-tuned ecosystem in the mouth can 
become disturbed, causing a dysbiotic shift 
and a loss of community balance or diversity 
in the biofilm,73 with a single or few species 
predominating, and an associated increased 
risk of disease. Modifiable factors driving oral 
dysbiosis include salivary gland dysfunction 
(that is, changes in saliva flow and/or composi-
tion), poor oral hygiene, gingival inflammation 
and lifestyle choices, including dietary habits 
and smoking.74,75 Figure 5a gives a summary of 
factors contributing to dysbiosis.
Fig. 5  (a) Causes of dysbiosis; (b) A model of dysbiosis (adapted from Marsh80)
In health, the majority of the bacteria have a symbiotic relationship with the host; for simplicity, these 
microorganisms are shown in green. Potentially cariogenic or periodontopathic bacteria (shown in red 
with dotted outlines) have been detected at healthy sites at low levels that are not clinically relevant; 
they may also be acquired from close partners (transmission), but again, their levels would be extremely 
low relative to the bacteria associated with health. In disease, there is an increase in the numbers and 
proportions of cariogenic or periodontopathic bacteria, and there may be increased biomass (especially 
in gingivitis). It is proposed that for this to happen, there has to be a change in local environmental 
conditions (major ecological pressure), which alters the competitiveness of bacteria within the biofilm and 
selects for those species that are most adapted to the new environment. The factors driving this selection 
need to be recognised and addressed for adequate and consistent disease prevention.
662 BRITISH DENTAL JOURNAL  |  VOLUME 221  NO. 10  |  NOVEMBER 18 2016
GENERAL
©
 
2016
 
British
 
Dental
 
Associ ati on.
 
All
 
ri ghts
 
reserved. ©
 
2016
 
British
 
Dental
 
Associ ati on.
 
All
 
ri ghts
 
reserved.
It is now an accepted concept that the bacteria 
historically considered as oral ‘pathogens’ can be 
found in low numbers at healthy sites, and oral 
disease occurs as a consequence of a deleterious 
change to the natural balance of the microbiota 
rather than as a result of exogenous ‘infection’.71 
In dysbiosis, these disease-associated bacteria 
can grow to markedly higher proportions 
than under healthy conditions, where they are 
normally minor and innocuous components in 
the biofilm.71
Alterations in the pattern of biofilm formation 
may result in dysbiotic microenvironments 
in the many distinct habitats in the mouth. 
The distinct, non-shedding structure of teeth 
(smooth surfaces, pits and fissures, proximal 
sites and exposed root surfaces) enables large 
masses of microbes to accumulate as dental 
plaque biofilm.76 Therefore, the plaque biofilm 
is not naturally shed as it accumulates, which is 
likely a key driver of dysbiosis in the absence of 
oral hygiene to disrupt and remove it.
Dysbiosis as origin of caries and 
periodontitis
Different theories on the relationship between 
plaque and dental disease have evolved over 
time.77 The ‘nonspecific plaque hypothesis’ 
(NSPH) has its origins in the nineteenth century, 
but was further refined over the next hundred 
years. Initially, the NSPH speculated that dental 
infections were caused by the nonspecific over-
growth of all bacteria in dental plaque. The NSPH 
was further extended to stipulate that destruc-
tive periodontitis was the result of subgingival 
colonisation, favoured by ecological changes 
associated with plaque accumulation, gingivitis 
and gingival exudate. These changes increase the 
numbers of microorganisms and alter their pro-
portions, but no single species appears in active 
sites that is not also commonly present in inactive 
sites.78 Since it was assumed that any plaque had 
the potential to cause disease, it was concluded 
that nonspecific mechanic removal of as much 
plaque as possible, for instance by tooth brushing 
or interdental cleaning, would be the best way of 
disease prevention.77
Evolving laboratory techniques allowed 
for the isolation and characterisation of 
more species in culture. The observation that 
kanamycin was particularly effective against 
caries-associated species, such as streptococci, 
led to the emergence of the ‘specific plaque 
hypothesis’, which proposed that only a few 
species in the oral microbiome are involved 
in the disease process, and that targeting these 
species with antibiotics could cure or prevent 
disease (initially caries and later periodonti-
tis).77,79 However, results from clinical studies 
employing antibiotics for the treatment of both 
conditions have been largely disappointing in 
terms of translation to day-to-day practice and 
magnitude of long-term clinical benefit.77 These 
outcomes could possibly be explained by the fact 
that, as mentioned before, a large proportion of 
microorganisms cannot be grown in culture, 
and thus bias may have been introduced by the 
isolation of only those that are cultivatable.
Following a renewed interest in the NSPH in 
the 1980s, an ecological plaque hypothesis was 
proposed to explain the relationship between 
the resident oral microbiota, the host environ-
ment and oral diseases (Fig. 5b).80 Substantial 
changes in a local environment can alter the 
competitiveness of plaque bacteria, leading 
to the enrichment of organisms most suited 
to the new environment.80 This hypothesis 
introduces the concept that disease can be 
prevented not only by directly inhibiting the 
putative pathogens, but also by interfering 
with the environmental factors driving the 
selection and enrichment of these bacteria.80 
For instance, in caries, an increased frequency 
of sugar intake, or a reduction in saliva flow, 
results in plaque biofilms that are exposed for 
longer and more regular periods to lower pH 
levels. This selects for organisms that produce 
acids themselves and/or are more tolerant of an 
acidic environment, at the expense of bacteria 
that thrive in neutral conditions or contrib-
ute to pH neutralisation.71,81 A contemporary 
model of host–microbe interactions in the 
pathogenesis of caries is shown in Figure 6. 
The ecological plaque hypothesis was 
further refined by the proposal that certain 
low-abundance microbial pathogens can 
cause inflammatory disease by interfering 
with the host immune system and remodel-
ling of the microbiota, leading to gingivitis and 
Fig. 6  A contemporary model of host–microbe interactions in the pathogenesis of caries 
(adapted from de Soet & Zaura and Takahashi)97,51 
In caries, carbohydrates are fermented to organic acids (for example, lactic acid), which lower the 
local pH resulting in net demineralisation of the tooth surface. This drives the selection of efficient 
acid-producing and acid-tolerating bacteria (dysbiosis). In contrast, in health, there is a more complex 
and balanced pattern of metabolism involving the catabolism of salivary proteins and glycoproteins, 
with the generation of alkali to neutralise any acid produced. The biofilm undergoes multiple pH 
cycles during the day, resulting in enamel de- and remineralisation (showed by ion efflux and influx 
into the enamel in the diagram). If fluoride ions are present in the biofilm, F– is then taken up in the 
superficial layer of enamel during the remineralisation phase, slowing down demineralisation during 
the acid challenge. Only when there are too many risk factors (for example, not sufficient time for 
pH neutralisation due to too frequent snacking, plaque being undersaturated with regard to fluoride, 
calcium and phosphate, low salivary clearance), demineralisation outweighs remineralisation and 
results in a net mineral loss with, in due time, enamel lesions.
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periodontitis. Figure 7 shows a contemporary 
model of host-microbe interactions in the 
pathogenesis of gingivitis and periodontitis.82 
Accumulation of biofilm triggers gingivitis; 
however, the presence of biofilm alone is not 
sufficient to advance into periodontitis. It is 
now recognised that complex interactions 
between immune response mediators and the 
biofilm are necessary requirements that lead 
to disease progression from gingivitis to peri-
odontitis.82 A dysbiotic microbial community 
subverts the host response so that most tissue 
damage is due to an inappropriate and uncon-
trolled level of inflammation.82–84 Local inflam-
mation resulting from biofilm accumulation 
causes an increased flow of the nutrient-rich 
GCF and potentially bleeding, whereby the 
site becomes deprived of oxygen, favouring 
the growth of anaerobic microbes.71 The 
inflammatory changes in the periodontal envi-
ronment provide an ideal environment for the 
growth of obligatory anaerobic and protein-
dependent bacteria that reside in the gingival 
crevice, driving a shift from a symbiotic micro-
biome to dysbiosis.71 Inflammation-induced 
micro-ulceration of the sulcular epithelium 
results in the leakage of blood (and thereby 
iron) into the gingival crevice. The resulting 
conditions are conducive for periodontitis-
associated species such as Porphyromonas 
gingivalis and Aggregatibacter actinomyce-
temcomitans to survive and flourish.85,86 The 
dysbiotic microbiota induces the destruction 
of the periodontal tissue by a dysregulated 
host inflammatory immune response, which in 
turn provides new tissue breakdown-derived 
nutrients for the bacteria.87 Through evolution, 
bacteria have adapted to take advantage of 
inflammation-derived nutrients, promoting 
further dysbiosis and tissue disruption, 
creating a self-perpetuating pathogenic cycle.87
The degree by which biofilm accumulation 
promotes periodontitis varies between individu-
als,82 according to their risk profile. In patients not 
susceptible to periodontitis, the inflammatory 
response in gingivitis is proportionate and self-
resolving, but in susceptible patients,  multiple 
genetic, epigenetic or patient-modifiable factors 
(tobacco, alcohol, diet, unregulated diabetes, 
stress, etc) can trigger an exaggerated, yet inef-
fective and chronic, non-resolving inflammation 
in the connective tissues supporting the teeth.82 
This is even more aggravated in diabetes, which 
is associated with metabolic dysregulation that 
modulates the inflammatory response, leading to 
a highly inflammatory state that further acceler-
ates tissue destruction and attachment loss.82
Although, to date, it is well established 
that particular microbial communities shift 
in response to disease, it remains to be elu-
cidated if there is a ‘healthy amount’ of these 
bacteria that is consistent across individuals,88 
or whether this differs between individuals 
due to different thresholds for activation and/
or deregulation of the host response.
Systemic consequences of oral 
dysbiosis
The coevolution to a harmonious coexistence 
is only valid as long microbes remain in their 
natural habitat and are not disseminated to 
other body sites, where they can cause disease. 
Dysbiosis in periodontal disease as a trigger 
of bacteraemia likely facilitates systemic dis-
semination of oral bacteria, and good oral 
hygiene is therefore crucial for controlling 
the total bacterial load.89,90 The link between 
oral pathogens and systemic effects has been 
evidenced by a recent study in animals, which 
found a direct effect of oral administration 
of P. gingivalis on the composition of the gut 
microbiome as well as inflammatory changes 
in various tissues and organs.91 Oral bacteria 
have been proposed to play a role in a number 
of systemic diseases, including cardiovas-
cular disease, rheumatoid arthritis, adverse 
pregnancy outcomes, stroke, inflammatory 
bowel disease and colorectal cancer, respiratory 
tract infection, meningitis or brain abscesses, 
lung, liver or splenic abscesses, appendicitis, 
pneumonia and diabetes.30,58,90,92,93
It is well established that severe periodontitis 
adversely affects glycaemic control in diabetes 
and glycaemia in subjects who do not have 
diabetes. Severe periodontitis poses an increased 
Fig. 7  A model of periodontitis pathogenesis (adapted from Meyle & Chapple)82 that has 
evolved from the classical model of Page & Kornman98 
Clinical health assumes some mild inflammatory changes that are proportionate to maintaining a 
resident ‘health-promoting’ periodontal microbiota. The relationship is symbiotic, with the host living 
harmoniously with its microbes. However, if the biofilm is allowed to accumulate and is not regularly 
disturbed/removed, certain pathogenic bacteria are able to emerge and an ‘incipient dysbiosis’ 
develops. For example, Porphyromonas gingivalis requires iron from haem and can start to establish 
itself and contribute to the dysbiosis, because as local inflammation increases it provides iron from 
gingival bleeding. In gingivitis, the host response remains proportionate, but due to the maturing 
biofilm, the associated inflammation does not resolve so easily and becomes chronic in nature, 
supporting the dysbiosis. Dependent upon various genetic, environmental and lifestyle risk factors, 
some susceptible patients will progress to periodontitis. The latter is driven by disproportionate and 
exaggerated host inflammatory immune responses that cause the majority of host tissue damage and 
drive a frank dysbiosis with failed resolution of the chronic destructive inflammation. A vicious cycle 
develops that sustains the disequilibrium, but symbiosis may be restored by regular and thorough 
biofilm disruption to help resolve the inflammation. DAMP – damage-associated molecular pattern; 
fMLP – f-Met-Leu-Phe; GCF – gingival crevicular fluid; LPS – lipopolysaccharide; MMP – matrix 
metalloproteinase; PMN – neutrophilic polymorphonuclear leucocyte.
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risk for the onset of type 2 diabetes, and there is a 
direct and dose-dependent relationship between 
the severity of periodontitis and diabetic compli-
cations.92 However, more research is needed to 
determine whether the periodontal microbiota 
has any direct impact on diabetes.
Analysis of the oral cavity and its microbi-
ome may be a useful tool to diagnose systemic 
diseases that have periodontal manifesta-
tions. Good oral hygiene to control the total 
microbial load is important to prevent dis-
semination to other body sites.90
Conclusions
Improved understanding of the 
holobiont – current and future 
implications for clinical practice
The diverse community that makes up the oral 
microbiome is finely tuned by nature to protect 
from disease, and it is of great importance to 
maintain its natural diversity. Modern lifestyles 
can disturb and upset the natural balance of our 
oral microbiome, and our clinical goal should 
be to re-establish its symbiotic equilibrium by 
whatever means are necessary and appropri-
ate in the individual patient. Thus, it is pivotal 
that both patients and healthcare professionals 
embrace the concept of a balanced oral micro-
biome and its importance in oral and systemic 
health. Treatment sessions should include 
prevention strategies, such as advice on oral 
hygiene practices and on diet and smoking. 
As a first approach, active maintenance of 
health rather than management of disease 
should be the primary concern for caregivers 
and patients alike. Oral healthcare profession-
als can achieve this by educating patients on 
appropriate lifestyle choices and the applica-
tion of effective plaque control techniques that 
preserve dental biofilms at levels compatible 
with oral health. This approach allows for the 
beneficial properties of the resident micro-
biota to be maintained while the risk of dental 
disease from excessive plaque accumulation is 
reduced. Once dysbiosis occurs, the treatment 
goal should be to re-establish the lost harmo-
nious balance by keeping good oral hygiene 
and modifying lifestyle factors such as diet 
and smoking. Indiscriminate use of antibiot-
ics for the treatment of oral diseases should 
be avoided, aiming to safeguard the beneficial 
oral microbiota and avoid antibiotic resistance. 
For the control of caries, in addition to use of 
topical fluoride, measures should be taken that 
encourage a shift away from an acidic envi-
ronment, through reduction in the amount 
and frequency of the consumption of sucrose 
and acidic drinks (even if the latter are sugar-
free), together with supplementation with 
agents that can reduce acid production and/
or promote alkali generation within dental 
plaque. For periodontal disease, treatment 
strategies should aim for mechanical reduction 
of accumulated biofilm by mechanical removal 
of plaque back to levels compatible with oral 
health. This would reduce inflammation and 
the accompanying flow of GCF, and promote 
a favourable microenvironment to support 
formation of a balanced microbiome. Where 
relevant, patients should also be advised on 
smoking cessation and control of diabetes.
A small study has recently shown that the 
composition of the subgingival microbiome 
at baseline, rather than the use of antibiotics, 
has a predictive potential on the long-term 
clinical outcome for treatment of chronic peri-
odontitis.94 While further research is needed 
to confirm details of predictive value, the 
finding underlines the important role of the 
oral microbiome, not only in disease, but also 
in the response of oral tissues.
Our current understanding of this rapidly 
evolving scientific field supports the notion 
that clinical practice needs to shift from its 
historical focus on management of caries and 
periodontitis by elimination of the microbiota, 
to a new focus on proactive management of oral 
health through an ecological approach to the 
holobiont. Future directions may include indi-
vidual assessment of the microbiome and the 
host response for the early detection of subjects 
at high risk, and personalised approaches to 
restore a health-associated oral microbiome 
after dysbiosis – potentially tantalising develop-
ments that would have direct implications for 
patient management in clinical practice.
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